MedTrace Logo

Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting

NCT01582841 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 247

Last updated 2016-08-31

No results posted yet for this study

Summary

The investigators research mobilizes the resources of an integrated health-delivery system with extensive electronic clinical data to implement and evaluate a new strategy to maximize screening of Colorectal Cancer (CRC) patients for Lynch Syndrome.

Conditions

Interventions

PROCEDURE

MSI screening test

All individuals in the intervention arm who consent to participate in the HNPCC screening will have their tumors evaluated for MSI.

Sponsors & Collaborators

  • Case Western Reserve University

    collaborator OTHER

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • Dana-Farber Cancer Institute

    collaborator OTHER

  • Vanderbilt University

    collaborator OTHER

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Katrina AB Goddard, PhD · Kaiser Permanente

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01582841 on ClinicalTrials.gov